|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/4985 | |||
| A61K 31/513 | |||
| A61K 31/519 | |||
| A61K 31/555 | |||
| A61K 31/675 | |||
| A61K 31/704 | |||
| A61K 31/7068 | |||
| A61P 35/00 | |||
| A61K 9/00 | |||
| A61P 1/00 | |||
| A61P 1/18 | |||
| A61P 13/08 | |||
| A61P 17/00 | |||
| A61P 43/00 | |||
| A61K 45/06 | |||
| A61K 47/26 | |||
| A61K 33/24 |
| (11) | Number of the document | 2350664 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09822657.4 |
| Date of filing the European patent application | 2009-10-21 | |
| (97) | Date of publication of the European application | 2011-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/061541 |
| Date | 2009-10-21 |
| (87) | Number | WO 2010/048330 |
| Date | 2010-04-29 |
| (30) | Number | Date | Country code |
| 107253 P | 2008-10-21 | US | |
| 118368 P | 2008-11-26 | US | |
| 150700 P | 2009-02-06 | US | |
| 151163 P | 2009-02-09 | US | |
| 244172 P | 2009-09-21 | US |
| (72) |
CURD, John G., US
KROLL, Stewart, US
MATTEUCCI, Mark, US
HART, Charles P., US
DUAN, Jian-Xin, US
SUN, Jessica D., US
|
| (73) |
ImmunoGenesis, Inc.,
909 Fannin St Suite 2000, Houston TX 77010,
US
|
| (54) | TREATMENT OF CANCER USING THE HYPOXIA ACTIVATED PRODRUG TH-302 IN COMBINATION WITH DOCETAXEL OR PEMETREXED |
| TREATMENT OF CANCER USING THE HYPOXIA ACTIVATED PRODRUG TH-302 IN COMBINATION WITH DOCETAXEL OR PEMETREXED |